AUTOMATED LIQUID HANDLING SYSTEMS MARKET ANALYSIS

Restaints

However, automated liquid handling systems are unaffordable for medical settings in emerging economies and small-scale laboratories, due to its high cost, which in turn is a major factor hindering the market growth. Moreover, stringent manufacturing requirements for receiving commercial license and market approvals by various governmental agencies such as the FDA and European Commission, increases the costs of these devices. Furthermore, integration of Information Technology (IT) in lab flow instruments requires high manufacturing expenses, leading to elevated prices of these devices. The low cost options available in portable formats do not provide accuracy and reliable test results. For instance, according to a report published by Food and Drug Association (FDA) and A2LA Certification Board, 2013, bending of tips due to external factors may result in around 10% errors in pipetting accuracy in low cost automated liquid handling systems.